Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1982-05-03
1983-10-25
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424180, 536 71, 435100, A61K 3171, C07H 1708, C12P 1962
Patent
active
044118929
ABSTRACT:
An antibiotic complex, consisting of two major components, has been isolated from fermentations of a new subspecies of Streptomyces albus culture. The two major components from the complex are two new macrolide antibiotics, which are active as antibacterial agents against certain gram-positive and gram-negative microorganisms.
REFERENCES:
patent: 4268665 (1981-05-01), Sakakibara et al.
patent: 4358584 (1982-11-01), Nash et al.
patent: 4366309 (1982-12-01), Ganguly et al.
Encyclopedia of Chemical Technology, Kirk-Othmer, Third Edition, vol. 2, John Wiley & Sons, 1978, p. 951.
The Merck Index, An Encyclopedia of Chemicals and Drugs, Ninth Edition, Merck & Co., Inc., Rahway, N.J., 1976, Entry 9486, p. 1260.
Celmer Walter D.
Cullen Walter P.
Shibakawa Riichiro
Tone Junsuke
Brown Johnnie R.
Frost Albert E.
Knuth Charles J.
Lumb J. Trevor
Pfizer Inc.
LandOfFree
Tylosin macrolide antibiotics from streptomyces does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tylosin macrolide antibiotics from streptomyces, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tylosin macrolide antibiotics from streptomyces will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-712515